LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 35 filers reported holding LYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,044,000 | +13.6% | 1,100,852 | 0.0% | 71.28% | +403.3% |
| Q2 2021 | $8,840,000 | -30.7% | 1,100,852 | 0.0% | 14.16% | -14.4% |
| Q1 2021 | $12,759,000 | +1.7% | 1,100,852 | 0.0% | 16.54% | +1.0% |
| Q4 2020 | $12,550,000 | +2.0% | 1,100,852 | 0.0% | 16.38% | -19.3% |
| Q3 2020 | $12,308,000 | -1.4% | 1,100,852 | 0.0% | 20.29% | +108.9% |
| Q2 2020 | $12,484,000 | – | 1,100,852 | – | 9.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,777,251 | $10,041,000 | 2.68% |
| Perceptive Advisors | 9,146,730 | $51,679,000 | 1.62% |
| VR Adviser, LLC | 924,170 | $5,222,000 | 1.03% |
| PURA VIDA INVESTMENTS, LLC | 2,576,196 | $14,556,000 | 0.84% |
| Nantahala Capital Management | 2,369,668 | $13,389,000 | 0.67% |
| Soleus Capital Management, L.P. | 592,417 | $3,347,000 | 0.52% |
| Ikarian Capital, LLC | 347,338 | $1,963,000 | 0.36% |
| Clearline Capital LP | 119,128 | $673,000 | 0.09% |
| CVI Holdings, LLC | 60,822 | $344,000 | 0.02% |
| HighMark Wealth Management LLC | 4,000 | $23,000 | 0.02% |